Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostaglandin Analogue Continuation and CMO Risk After Cataract Surgery
NCT03292796Phase 2Completed
- Start
- Dec 2016
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in open-angle glaucoma (OAG) and ocular hypertension. Started Dec 2016; status: completed.
02
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT03292796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03292796.